Newsletters

Leukocyte Telomere Attrition following Radiotherapy in Prostate Cancer: A Prospective Study

January 23, 2026

Newsletters

Circulating Tumor Cells As a Window into Lethality in Prostate Cancer

January 23, 2026

Newsletters

Recent Advances and Future Prospects of Immunotherapeutic Approaches in Prostate Cancer

January 23, 2026

All Articles by Author:

lbeveridge

Hematopoiesis News

Comparison of the Impact of Two Post-remission Therapy Regimens on Cardiac Events in Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

[International Journal of Hematology] Scientists compared the incidence of cardiac events and event-free survival after allogeneic hematopoietic stem cell transplantation at two Japanese hospitals between High-dose cytarabine and anthracycline-containing post-remission therapy to clarify the safety of post-remission therapy.

Read more...

1...1,085 1,0861,087Page 1,087 of 1,087

Popular

Leukocyte Telomere Attrition following Radiotherapy in Prostate Cancer: A Prospective Study

[Scientific Reports] Researchers analyzed the influence of radiotherapy on leucocyte telomere length in prostate cancer patients. A total of 314 patients treated with curative radiotherapy for prostate cancer were included in the present prospective study.

Circulating Tumor Cells As a Window into Lethality in Prostate Cancer

[Nature Reviews Urology] Understanding the clinical utility of circulating tumour cells (CTCs) and future innovations is crucial to incorporating CTCs into the clinical management of prostate cancer.

Recent Advances and Future Prospects of Immunotherapeutic Approaches in Prostate Cancer

[Journal of Translational Medicine] The authors provide a comprehensive summary of current advances and persisting challenges in the field of prostate cancer immunotherapy.